bg
S

Spero Therapeutics (SPRO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Spero Therapeutics (SPRO)

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. Its lead product candidate, tebipenem HBr (tebipenem pivoxil ... Read more

  • USD1.77
  • USD1.82
  • USD1.77
  • USD3.18
  • 5.20%
  • 54M
  • 50.00
  • 302.81k
  • 96M
  • 0.68
  • 75.00%

Unlock More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.